Stoke Therapeutics, Inc. (STOK) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-06

Stoke Therapeutics, Inc. (STOK) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 3 Form 8-K material event filings were reported by STOK in the last 90 days. 3 Form 144 notices of proposed sale were filed for STOK stock. InsiderAlpha tracks every STOK SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Stoke Therapeutics, Inc. (STOK)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001623526

90-Day SEC Filing Activity

Form 4 filings (90d)	11
Form 8-K filings (90d)	3
Form 144 notices (90d)	3
Latest Form 4 filing	2026-07-06

Recent STOK Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-01	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale	6.7K	$32.62	$219K	SEC
2026-07-01	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale	500	$33.27	$17K	SEC
2026-06-16	Allan Jonathan	GENERAL COUNSEL & CORP SEC	S — Open-market sale	1.5K	$29.95	$44K	SEC
2026-06-01	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale	1.8K	$30.58	$55K	SEC
2026-05-01	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale	2.2K	$32.79	$74K	SEC
2026-04-01	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale [10b5-1]	1.8K	$32.66	$60K	SEC
2026-03-20	Allan Jonathan	GENERAL COUNSEL & CORP SEC	S — Open-market sale [10b5-1]	601	$34.41	$21K	SEC
2026-03-20	Allan Jonathan	GENERAL COUNSEL & CORP SEC	S — Open-market sale [10b5-1]	8.7K	$33.64	$292K	SEC
2026-03-19	Ticho Barry	CHIEF MEDICAL OFFICER	S — Open-market sale [10b5-1]	1.5K	$29.99	$44K	SEC
2026-03-19	Ticho Barry	CHIEF MEDICAL OFFICER	M — Option exercise [10b5-1]	1.4K	$2.19	$3K	SEC
2026-03-18	Allan Jonathan	GENERAL COUNSEL & CORP SEC	S — Open-market sale	334	$31.79	$11K	SEC
2026-03-18	Hoitt Jason	Chief Patient Officer	S — Open-market sale	30	$32.85	$986	SEC
2026-03-18	Leggett Thomas	Chief Financial Officer	S — Open-market sale	172	$31.79	$5K	SEC
2026-03-18	Leggett Thomas	Chief Financial Officer	S — Open-market sale	37	$32.85	$1K	SEC
2026-03-18	Leggett Thomas	Chief Financial Officer	S — Open-market sale	2.2K	$31.28	$68K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Stoke Therapeutics, Inc. (STOK). Updated in real time as new filings are submitted to the SEC.

Most-Active STOK Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Ticho Barry	4	$365K
LEVIN ARTHUR A	1	—
Allan Jonathan	1	$44K
TZIANABOS ARTHUR	1	—
Krainer Adrian R.	1	—

Recent STOK Form 8-K Material Events

2026-06-30 — Item 7.01, 8.01, 9.01 [SEC]
2026-06-04 — Item 5.07 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-04-07 — Item 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
Stoke Therapeutics appointed G. Clare Kahn, Ph.D. to its Board of Directors on April 3, 2026, increasing board size to ten directors. Dr. Kahn, an independent director, was also appointed to the Nominating and Corporate Governance Committee and as chairperson of the Research and
2026-03-27 — Item 4.01, 9.01 · Other · neutral [SEC]
Stoke Therapeutics dismissed KPMG LLP as its independent registered public accounting firm on March 23, 2026, and appointed Ernst & Young LLP as the new auditor for fiscal year 2026. The dismissal was not due to any disagreements on accounting principles, audit scope, or reportab

Recent STOK Form 144 Notices of Proposed Sale

2026-07-01 — — [SEC]
2026-06-16 — — [SEC]
2026-05-01 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-07-06 — Ticho Barry (CHIEF MEDICAL OFFICER)
2026-06-18 — Allan Jonathan (GENERAL COUNSEL & CORP SEC)
2026-06-05 — TZIANABOS ARTHUR (Insider)
2026-06-05 — Smith Julie (Insider)
2026-06-05 — LEVIN ARTHUR A (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in STOK insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

STOK Insider Trading — FAQ

What is the latest insider trade for STOK?: Stoke Therapeutics, Inc. (STOK) had 11 insider filings in the last 90 days, with the most recent on 2026-07-06. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying STOK stock?: 0 insider purchases of STOK were filed in the last 90 days.
How many insiders are selling STOK stock?: 0 insider sales of STOK were filed in the last 90 days.
Where can I see STOK SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every STOK SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live STOK dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.